Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1) > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):19-25

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Rivista di Dermatologia e Malattie Sessualmente Trasmesse


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

ORIGINAL ARTICLE  


Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):19-25

DOI: 10.23736/S0392-0488.16.05373-6

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in Day Surgery Unit

Mauro MONTUORI 1 , Letizia SANTURRO 1, Andrea FELIZIANI 2, Flavio DE SANCTIS 2, Edoardo RICCIARDI 2, Daniele GAUDIO 3, Elena CAMPIONE 4, Luca BIANCHI 4, Maria B. SILVI 3, Piero ROSSI 1

1 Department of Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy; 2 Department of Surgery, University Hospital of Tor Vergata, Rome, Italy; 3 Department of Anesthesiology and Intensive Care, University Hospital of Tor Vergata, Rome, Italy; 4 Department of Dermatologic Surgery, University Hospital of Tor Vergata, Rome, Italy


PDF  


BACKGROUND: The aim of this study was to evaluate feasibility, safety and efficacy in day surgery of electrochemotherapy (ECT) using bleomycin in non-melanoma head and neck skin cancer.
METHODS: We performed a prospective study on fifteen patients treated at the General Surgery Department at University Hospital of Tor Vergata, Rome between April 2011 and February 2013.
RESULTS: We observed 100% complete response evaluated with WHO criteria at 6 weeks after treatment. No partial response was achieved.
CONCLUSIONS: ECT is a simple, highly effective and safe treatment for head and neck non melanoma skin cancer. In our experience ECT can be performed safely in Day Surgery also in patients ASA III. Side effects associated with ECT are minimal and the treatment is well tolerated also by older patients, with minimal impairment of organ function and healthy tissues and with good esthetic results. We would encourage this treatment especially for older patients with multiple comorbidities, in which conventional surgical approach is not easily practicable.


KEY WORDS: Electrochemotherapy - Bleomycin - Head and neck neoplasms - Carcinoma, basal cell - Carcinoma, squamous cell

inizio pagina

Publication History

Issue published online: January 8, 2018
Article first published online: July 5, 2016
Manuscript accepted: July 4, 2016
Manuscript revised: June 27, 2016
Manuscript received: March 29, 2016

Per citare questo articolo

Montuori M, Santurro L, Feliziani A, De Sanctis F, Ricciardi E, Gaudio D, et al. Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in Day Surgery Unit. G Ital Dermatol Venereol 2018;153:19-25. DOI: 10.23736/S0392-0488.16.05373-6

Corresponding author e-mail

mauro.montuori@hotmail.it